NCT01950741View on ClinicalTrials.gov

Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

August 31, 2015

Conditions
Exudative Age-related Macular DegenerationPolypoidal Choroidal Vasculopathy
Interventions
DRUG

aflibercept

Aflibercept is injected intravitreally though the pars plana using 30G needle-attached syringe.

Trial Locations (8)

614-735

Busan Paik Hospital, Busanjin-gu

612-030

Haeundae Paik Hospital, Haeundae

602-702

Gospel Hospital, Seo-gu

602-739

Pusan National University Hospital, Seo-gu

Unknown

Keimyung University Dongsan Medical Center, Jung-gu

Kyungpook National University Hospital, Jung-gu

705-717

Yeungnam University Medical Center, Nam-gu

660-702

Gyeongsang National University Hospital, Jinju

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Pusan National University Hospital

OTHER